Operating Segments (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Segment reporting
Revenues	$ 214,824	$ 505,288	$ 362,417	$ 1,429,842
Loss from operations	(3,009,645)	(2,813,872)	(5,243,252)	(11,287,661)
Amortization and depreciation	8,840	17,802	17,739	35,448
Other income, net	247,835	37,109	118,964	92,671
Share-based compensation	80,621	81,003	175,426	144,694
Identifiable Assets	29,610,289		29,610,289		$ 19,891,235
Public Health Solutions
Segment reporting
Revenues	214,824	468,009	362,417	1,376,818
Loss from operations	(231,954)	(50,737)	(362,735)	(209,239)
Amortization and depreciation	311	7,318	627	14,621
Share-based compensation	7,189	8,377	13,484	17,842
Identifiable Assets	123,427		123,427		176,447
Specialized BioTherapeutics
Segment reporting
Revenues		37,279		53,024
Loss from operations	(1,720,566)	(1,808,652)	(2,832,974)	(9,166,503)
Amortization and depreciation	1,862	3,167	3,761	6,237
Other income, net	41,001	35,091	125,635	68,706
Share-based compensation	28,731	18,962	58,310	44,251
Identifiable Assets	34,272		34,272		147,784
Corporate
Segment reporting
Loss from operations	(1,057,125)	(954,483)	(2,047,543)	(1,911,919)
Amortization and depreciation	6,667	7,317	13,351	14,590
Other income, net	206,834	2,018	(6,671)	23,965
Share-based compensation	44,701	$ 53,664	103,632	$ 82,601
Identifiable Assets	$ 29,452,590		$ 29,452,590		$ 19,567,004